Myleran (GT 41) in the Treatment of Leukaemia.1
- 12 January 1955
- journal article
- research article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 151 (4), 295-306
- https://doi.org/10.1111/j.0954-6820.1955.tb10296.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- β-Naphthyl-di-chloroethylamine in the Treatment of Malignant Diseases, Particularly Hodgkin's DiseaseActa Medica Scandinavica, 2009
- The effect of 1,4-dimethanesulfonyloxybutane (GT-41 or myleran) upon leukemiaCancer, 1954
- MYLERAN IN CHRONIC MYELOID LEUKÆMIA RESULTS OF TREATMENTThe Lancet, 1953
- MYLERAN IN CHRONIC MYELOID LEUKÆMIA CHEMICAL CONSTITUTION AND BIOLOGICAL ACTIONThe Lancet, 1953
- A TRIAL OF $beta;-NAPHTHYLDI-2-CHLOROETHYLAMINE (R48) IN LEUKqMIA, HODGKIN'S DISEASE, AND ALLIED DISEASESThe Lancet, 1950
- Effects upon tumours of Various HaloalkylarylaminesNature, 1948
- LEUKÆMIA TREATED WITH URETHANE COMPARED WITH DEEP X-RAY THERAPYThe Lancet, 1946